Intranasal oxytocin

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
127	前頭側頭葉変性症	4

告示番号	疾患名（ページ内リンク）	臨床試験数
193	プラダー・ウィリ症候群	18

127. 前頭側頭葉変性症

臨床試験数 : 90 / 薬物数 : 87 - (DrugBank : 30) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 88

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03260920 (ClinicalTrials.gov)	January 31, 2018	19/7/2017	Intranasal Oxytocin for Frontotemporal Dementia	A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia	Frontotemporal Dementia	Drug: Syntocinon	Lawson Health Research Institute	Weston Brain Institute;Canadian Institutes of Health Research (CIHR);Berry Consultants	Active, not recruiting	30 Years	80 Years	All	112	Phase 2	United States;Canada
2	NCT01937013 (ClinicalTrials.gov)	September 12, 2013	3/9/2013	Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia	Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia	Frontotemporal Dementia	Drug: Intranasal oxytocin;Drug: Saline Nasal Mist	Lawson Health Research Institute	Canadian Institutes of Health Research (CIHR)	Completed	30 Years	85 Years	All	52	Phase 2	Canada
3	NCT01386333 (ClinicalTrials.gov)	June 2011	29/6/2011	Safety Study of Intranasal Oxytocin in Frontotemporal Dementia	A Phase I Dose Finding Study of Intranasal Oxytocinin Frontotemporal Dementia, Protocol # FTDOXY10EF ...	Frontotemporal Dementia	Drug: oxytocin;Drug: Saline Nasal Mist	Lawson Health Research Institute	The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)	Completed	30 Years	80 Years	Both	23	Phase 1	Canada
4	NCT01002300 (ClinicalTrials.gov)	September 2009	23/10/2009	Oxytocin and Social Cognition in Frontotemporal Dementia	Investigation of the Effects of Intranasal Oxytocinon Cognition and Emotion Processing in Frontotemp ...	Frontotemporal Dementia;Pick's Disease	Drug: intranasal oxytocin	Lawson Health Research Institute	The Alzheimer Society London and Middlesex	Completed	30 Years	80 Years	Both	24	N/A	Canada

First Previous1Next Last

193. プラダー・ウィリ症候群

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

trials per page:

Showing 1 to 10 of 18 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05298085 (ClinicalTrials.gov)	April 5, 2022	17/3/2022	Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome	Effect of Intranasal Oxytocinon Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Children ...	Prader-Willi Syndrome	Drug: Oxytocin nasal spray;Drug: Placebo	University Hospital, Toulouse	NULL	Active, not recruiting	2 Years	17 Years	All	25	Phase 2/Phase 3	France
2	EUCTR2019-002385-12-NL (EUCTR)	26/08/2021	08/09/2020	Oxytocin treatment in neonates and infants aged from 0 to 3 months with prader-willi syndrome	Oxytocintreatment in neonates and infants aged from 0 to 3 months with prader-willi syndrome: a stud ...	Prader-Willi Syndrom;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 3	France;Belgium;Germany;Netherlands
3	EUCTR2019-002385-12-DE (EUCTR)	07/07/2021	21/04/2021	OXYTOCIN TREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME	OXYTOCINTREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME: A STUD ...	Prader-Willi Syndrome;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 3	France;Belgium;Netherlands;Germany;Italy
4	NCT04283578 (ClinicalTrials.gov)	March 10, 2020	19/2/2020	Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome	OxytocinTreatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Stu ...	Prader-Willi Syndrome	Drug: OT;Drug: Placebo comparator	University Hospital, Toulouse	International Clinical Trials Association;Epidemiological and Clinical Research Information Network	Completed	N/A	92 Days	All	52	Phase 3	France
5	EUCTR2019-002385-12-FR (EUCTR)	27/08/2019	12/06/2019	OXYTOCIN TREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME	OXYTOCINTREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME: A STUD ...	Prader-Willi Syndrom;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 3	France;Belgium;Germany;Netherlands;Italy
6	EUCTR2017-003423-30-NL (EUCTR)	12/12/2017	04/10/2017	Intranasal administration of oxytocin in children with Prader-Willi syndrome	Randomized, double-blind, placebo-controlled oxytocinand dose-response trial in children with Prader ...	Prader-Willi syndrome MedDRA version: 20.0;Level: PT;Classification code 10036476;Term: Prader-Willi ...	Trade Name: Syntocinon nasal spray Product Name: oxytocin Product Code: oxytocin	Dutch Growth Research Foundation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	33	Phase 2;Phase 3	Netherlands
7	NCT03245762 (ClinicalTrials.gov)	August 1, 2017	7/8/2017	Intranasal Oxytocin for Infants With Prader-Willi Syndrome	Intranasal Oxytocinfor Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional P ...	Prader-Willi Syndrome	Drug: Oxytocin;Drug: Placebo	University of Florida	Prader-Willi Syndrome Association	Completed	N/A	6 Months	All	15	Phase 1/Phase 2	United States
8	EUCTR2016-003820-22-NL (EUCTR)	22/12/2016	12/10/2016	Intranasal administration of oxytocin in children with Prader-Willi Syndrome	Intranasaladministration of oxytocinin children with Prader-Willi Syndrome. A randomized, open-label ...	Prader-Willi syndrome MedDRA version: 19.0;Level: PT;Classification code 10036476;Term: Prader-Willi ...	Trade Name: Syntocinon nasal spray Product Name: oxytocin Product Code: oxytocin	Dutch Growth Research Foundation	NULL	Not Recruiting			Female: yes Male: yes		Phase 3	Netherlands
9	NCT03114371 (ClinicalTrials.gov)	November 28, 2016	10/3/2017	Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years	Effects of IntranasalAdministrations of Oxytocinon Behavioural Troubles, Hyperphagia and Social Skil ...	Prader-Willi Syndrome	Drug: Oxytocin;Drug: Placebo	University Hospital, Toulouse	NULL	Completed	3 Years	12 Years	All	40	N/A	France
10	EUCTR2016-003273-18-FR (EUCTR)	14/11/2016	22/08/2016	Oxytocin intranasal administrations in children with Prader-Willi syndrome aged from 3 to 12 years.	Effects of intranasaladministrations of oxytocinon beahvioural troubles, hyperphagia and social skil ...	Prader-Willi Syndrom;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Trade Name: Syntocinon	University Hospital of Toulouse	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 3	France

First Previous1 2Next Last